Perelman School of Medicine

facebook twitter google print email
Media Contact:Anna Duerr | anna.duerr@uphs.upenn.edu | 215-349-8369September 3, 2014

Penn Study Shows Better Outcomes for Sepsis Patients Treated in Hospitals with Higher Volume of Cases

Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.

Rural Hospitals Pressured to Close as Healthcare System Changes

September 3, 2014

Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School is quoted from his book Reinventing American Health Care.

Article Source: Reuters

Study: Experimental Drug for Heart Failure Looks to Be Biggest Advance in Decades

September 1, 2014

The Perelman School of Medicine’s Mariell Jessup and Lee Goldberg comment on a study on an experimental drug for heart failure.

Article Source: Philadelphia Inquirer
facebook twitter google print email
Media Contact:Amanda Mott | ammott@upenn.edu | 215-898-1422September 4, 2014

New Penn Integrates Knowledge Website Highlights Program’s Broad Impact

blurb: 
Since 2005 the University of Pennsylvania‘s Penn Integrates Knowledge program has brought to campus exceptional faculty members whose research and teaching exemplify the integration of knowledge across disciplines.

Since 2005 the University of Pennsylvania‘s Penn Integrates Knowledge program has brought to campus exceptional faculty members whose research and teaching exemplify the integration of knowledge across disciplines. 

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658August 26, 2014

Drug for Rare Blood Disorder Developed at Penn Receives Orphan Drug Status from European Union

A Penn Medicine-developed drug has received orphan status in Europe this week for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658August 28, 2014

Penn Medicine Study: Attacking a Rare Disease at its Source With Gene Therapy

Treating the rare disease MPS I is a challenge. MPS I, caused by the deficiency of a key enzyme called IDUA, eventually leads to the abnormal accumulation of certain molecules and cell death. 

Lively Accounts Examining Death

August 25, 2014

The Perelman School of Medicine’s David Casarett discusses his book Shocked: Adventures in Bringing Back the Recently Dead.

Article Source: New York Times
facebook twitter google print email
Media Contact:Greg Richter | gregory.richter@uphs.upenn.edu | 215-614-1937August 25, 2014

Penn Study Shows 25 Percent Fewer Opioid-Related Deaths in States Allowing Medical Marijuana

On average, states allowing the medical use of marijuana have lower rates of deaths resulting from opioid analgesic overdoses than states without such laws. Opioid analgesics, such as OxyContin, Percocet and Vicodin, are prescribed for moderate to severe pain, and work by suppressing a person’s perception of pain.

Check Up: Penn Doctor’s Study Links Parkinson’s and Depression

August 24, 2014

Daniel Weintraub of the Perelman School of Medicine comments on how psychiatric problems might be early symptoms of a movement disorder.

Article Source: Philadelphia Inquirer
facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660August 22, 2014

Penn Study: Electronic Alerts Significantly Reduce Catheter-Associated Urinary Tract Infections

A Penn Medicine team has found that targeted automated alerts in electronic health records significantly reduce urinary tract infections in hospital patients with urinary catheters. In addition, when the design of the alert was simplified, the rate of improvement dramatically increased.